Inventor · disambiguated record
Stephanie Schorge
Also filed as: SCHORGE STEPHANIE
6 granted patents·5 pending applications·13 citations·filing 1999–2023
74Inventor score
Files withUCL BUSINESS LTD6BROWN UNIVERSITY RES FOUNDDATI1SCION PHARMACEUTICALS INC1UCL BIOMEDICA PLC1UCL BUSINESS PLC1
Top patents by PatentIndex Score
11 records- 0167US7018832B2Human N-type calcium channel isoform and uses thereofUNIV BROWN RES FOUND·Filed 2001·Granted Mar 28, 2006·2 cites·7 claims
- 0258US2025144244A1Treatment of acquired focal epilepsyUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 0357US6353091B1Human N-type calcium channel isoformBROWN UNIVERSITY RES FOUNDDATI·Filed 1999·Granted Mar 5, 2002·11 cites·6 claims
- 0457US2025064974A1Endogenous gene regulation to treat neurological disorders and diseasesUCL BUSINESS LTD·Filed 2023·Application pending·0 cites
- 0550US11779658B2Expression vectors comprising engineered genesUCL BUSINESS LTD·Filed 2018·Granted Oct 10, 2023·0 cites·25 claims
- 0649US8038995B2Human N-type calcium channel isoform and uses thereofSCION PHARMACEUTICALS INC·Filed 2006·Granted Oct 18, 2011·0 cites·5 claims
- 0749US2023330265A1GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOFUCL BUSINESS LTD·Filed 2021·Application pending·0 cites
- 0848US2006269935A1Genetic predictor for clinical use of drugs used in the treatment of neurological conditionsUCL BIOMEDICA PLC·Filed 2006·Application pending·0 cites
- 0948US2023165975A1Activity-dependent gene therapy for neurological disordersUCL BUSINESS LTD·Filed 2021·Application pending·0 cites
- 1046US10525103B2Combined use of a vector encoding a modified receptor and its exogenous agonist in the treatment of seizuresUCL BUSINESS LTD·Filed 2019·Granted Jan 7, 2020·0 cites·4 claims
- 1135US10391145B2Combined use of a vector encoding a modified receptor and its exogenous agonist in the treatment of seizuresUCL BUSINESS PLC·Filed 2015·Granted Aug 27, 2019·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Stephanie Schorge files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →